Skip to main content
. Author manuscript; available in PMC: 2010 Aug 6.
Published in final edited form as: Vaccine. 2009 Jun 27;27(36):4917–4922. doi: 10.1016/j.vaccine.2009.06.040

Figure 4.

Figure 4

Survival likelihoods of neonatal CD-1 mice following oral challenge with wild-type O1 Ogawa V. cholerae O395. Three- to five-day-old pups (cohort size 15) were gavaged with 50 μl of a preparation containing 106 or 107 CFU of V. cholerae O395 mixed 1:1 with pooled day 56 serum from mice transcutaneously immunized with neoglycoconjugate (CHO-BSA) and immunoadjuvantative cholera toxin (CT) or CT alone. Challenged mice were kept at 30°C and monitored for death every 3 to 6 h starting 18 h after oral challenge till 48 h after oral challenge. Survival curves were compared by log rank testing.